Press Releases

Active Biotech raises SEK 149 million through a directed share issue
April 1, 2010 15:00 (CEST)
Number of shares and votes in Active Biotech
March 31, 2010 16:00 (CEST)
Number of shares and votes in Active Biotech
February 26, 2010 08:30 (CET)
Active Biotech AB Year-end Report, January - December 2009
February 11, 2010 08:30 (CET)
Exploratory data presented for Active Biotech's ANYARA project
February 10, 2010 20:02 (CET)
TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS
February 8, 2010 14:30 (CET)
Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients
December 14, 2009 08:30 (CET)
Active Biotech AB Interim Report, January - September 2009
November 5, 2009 08:30 (CET)
Active Biotech's election committee appointed
November 5, 2009 08:30 (CET)
RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities
October 5, 2009 11:30 (CEST)